- Home
- GTIM vs GTBP Comparison
GTIM vs GTBP Comparison
Compare GTIM & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTIM | GTBP |
|---|---|---|
| Founded | 1987 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7M | 12.4M |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GTIM | GTBP |
|---|---|---|
| Price | $1.28 | $5.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 40.2K | ★ 54.5K |
| Earning Date | 08-06-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.75 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $142,315,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.10 | ★ N/A |
| Revenue Growth | ★ 3.01 | N/A |
| 52 Week Low | $1.10 | $0.22 |
| 52 Week High | $1.66 | $287.50 |
Technical Indicators
Market Signals| Indicator | GTIM | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 32.31 | 36.57 |
| Support Level | $1.14 | $0.22 |
| Resistance Level | $1.34 | $7.73 |
| Average True Range (ATR) | 0.06 | 0.62 |
| MACD | -0.00 | 0.43 |
| Stochastic Oscillator | 27.27 | 17.70 |
Price Performance
Historical ComparisonAbout GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.